207 studies found for:    novel influenza a (h1n1)
Show Display Options
Rank Status Study
21 Enrolling by invitation Analysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCR
Condition: H1N1 Influenza Virus
Intervention:
22 Recruiting Safety and Efficacy of Investigational Immune Plasma in Treating Influenza A
Condition: Influenza A
Interventions: Biological: Anti-Influenza Plasma;   Behavioral: Standard Care
23 Completed
Has Results
Relenza® Sentinel Site Monitoring Program in Japan
Condition: Influenza, Human
Intervention: Drug: zanamivir
24 Completed Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
Intervention:
25 Unknown  Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
Conditions: Serology Analysis;   Novel H1N1 Influenza Vaccination;   Pediatric Haemato-oncology Patients
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
26 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
Condition: Influenza
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
27 Completed Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults
Condition: Influenza
Interventions: Biological: VAX128;   Biological: Placebo
28 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Condition: Swine-Origin Influenza A H1N1 Virus
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
29 Completed A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza
Condition: H1N1 Virus
Intervention:
30 Unknown  The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A
Condition: H1N1 Influenza
Interventions: Drug: Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);   Drug: Placebo (digestive tablet)
31 Unknown  Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
Condition: Influenza
Intervention: Biological: Inactivated H1N1 vaccine
32 Completed
Has Results
Safety Study to Evaluate FluMist in Immunocompromised Children
Condition: Cancer
Interventions: Biological: FluMist;   Biological: Placebo
33 Completed
Has Results
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Condition: Novel 2009 Influenza H1N1
Interventions: Biological: MF59-eH1N1_f;   Biological: eH1N1_f
34 Active, not recruiting Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
Conditions: Influenza;   HIV Infections
Intervention:
35 Completed
Has Results
A Phase 2 Study to Evaluate Immune Responses of FluMist®
Condition: Influenza Vaccine
Interventions: Biological: TIV, Trivalent Inactivated Influenza Virus Vaccine;   Biological: FluMist, Influenza Virus Vaccine Live
36 Unknown  Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
37 Completed
Has Results
A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk
Conditions: Influenza;   Influenza Vaccines
Intervention: Biological: Fluviral
38 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
39 Completed Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
Condition: Pandemic Influenza Disease
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
40 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Conditions: H1N1 Influenza Virus;   Invasive Solid Tumors
Interventions: Biological: adjuvanted A(H1N1) influenza vaccine;   Biological: non-adjuvanted A(H1N1) influenza vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years